Citation Impact
Citing Papers
Phase II Study of Autologous Monocyte-Derived mRNA Electroporated Dendritic Cells (TriMixDC-MEL) Plus Ipilimumab in Patients With Pretreated Advanced Melanoma
2016
Vaccination with LAG-3Ig (IMP321) and Peptides Induces Specific CD4 and CD8 T-Cell Responses in Metastatic Melanoma Patients—Report of a Phase I/IIa Clinical Trial
2015
The AKT-mTOR pathway plays a critical role in the development of leiomyosarcomas
2007 Standout
A RASSF1A-HIF1α loop drives Warburg effect in cancer and pulmonary hypertension
2019 StandoutNobel
Haemodynamic definitions and updated clinical classification of pulmonary hypertension
2018 Standout
Nucleoside-modified VEGFC mRNA induces organ-specific lymphatic growth and reverses experimental lymphedema
2021 StandoutNobel
Bench-to-bedside review: microvascular dysfunction in sepsis--hemodynamics, oxygen transport, and nitric oxide.
2003
FoxOs Enforce a Progression Checkpoint to Constrain mTORC1-Activated Renal Tumorigenesis
2010 StandoutNobel
Dexmedetomidine vs Midazolam for Sedation of Critically Ill Patients<subtitle>A Randomized Trial</subtitle>
2009 Standout
Clinical and genetic aspects of primary ciliary dyskinesia/Kartagener syndrome
2009
Idiopathic pulmonary fibrosis
2017 Standout
Acute kidney injury
2012 Standout
The Clinical Spectrum of Lymphatic Disease
2008
Apheresis to treat systemic vasculitis
2017
The Tuberous Sclerosis Complex
2006 Standout
O2 sensing in hypoxic pulmonary vasoconstriction: the mitochondrial door re-opens
2002
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Guidelines on the use of therapeutic apheresis in clinical practice—Evidence‐based approach from the apheresis applications committee of the American Society for Apheresis
2010
Effect of plasma exchange on in-hospital mortality in patients with pulmonary hemorrhage secondary to antineutrophil cytoplasmic antibody-associated vasculitis: A propensity-matched analysis using a nationwide administrative database
2018
Decline in Lung Function in Patients With Lymphangioleiomyomatosis Treated With or Without Progesterone
2004
Hypoxia-induced changes in pulmonary and systemic vascular resistance: Where is the O2 sensor?
2010
Long-term outcome of severe alveolar haemorrhage in ANCA-associated vasculitis: a retrospective cohort study
2013
Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex
2004 StandoutNobel
The molecular basis of human retinal and vitreoretinal diseases
2010 Standout
Mutation analysis of the TSC1 and TSC2 genes in Japanese patients with pulmonary lymphangioleiomyomatosis
2002
Central nervous system injury-induced immune deficiency syndrome
2005 Standout
Lymphangiogenesis: Molecular Mechanisms and Future Promise
2010 Standout
A global view of pulmonary hypertension
2016 Standout
Mitochondrial formation of reactive oxygen species
2003 Standout
Updated Clinical Classification of Pulmonary Hypertension
2009 Standout
Pulmonary Hypertension in Chronic Lung Diseases
2013
The clinical utility of bronchoalveolar lavage in diffuse parenchymal lung disease
2010
Microscopic Polyangiitis
2010
Heat Shock Protein A12B Protects Vascular Endothelial Cells Against Sepsis-Induced Acute Lung Injury in Mice
2017 Standout
Influence of Airway Management on Ventilator-Associated Pneumonia
1998
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Current Diagnosis and Management of Immune Related Adverse Events (irAEs) Induced by Immune Checkpoint Inhibitor Therapy
2017
Sirolimus for Angiomyolipoma in Tuberous Sclerosis Complex or Lymphangioleiomyomatosis
2008 Standout
Delivery technologies for cancer immunotherapy
2019 Standout
Endothelium-derived mediators and hypoxic pulmonary vasoconstriction
2002
Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2017 Standout
Anti-Glomerular Basement Membrane Disease
2017
The impact of emphysema in pulmonary fibrosis
2013
Endoplasmic Reticulum Stress and the Inflammatory Basis of Metabolic Disease
2010 Standout
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
2016 Standout
Lymphangioleiomyomatosis — a wolf in sheep’s clothing
2012
Tuberous sclerosis
2008 Standout
Hypoxia inducible factor-1-dependent up-regulation of BMP4 mediates hypoxia-induced increase of TRPC expression in PASMCs
2015 StandoutNobel
mTOR treatment in lymphangioleiomyomatosis: the role of everolimus
2016
Updated Clinical Classification of Pulmonary Hypertension
2013 Standout
Evidence That Lymphangiomyomatosis Is Caused by TSC2 Mutations: Chromosome 16p13 Loss of Heterozygosity in Angiomyolipomas and Lymph Nodes from Women with Lymphangiomyomatosis
1998
Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies
2015
Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force
2007
Vascular pharmacology of acute lung injury and acute respiratory distress syndrome
2002
Apheresis for MPO-ANCA-associated RPGN—indications and efficacy: Lessons learned from Japan nationwide survey of RPGN
2005
Pulmonary renal syndrome: A 4-year, single-center experience
2002
Clinical and economic consequences of ventilator-associated pneumonia: A systematic review
2005
Coinhibitory Receptor Expression and Immune Checkpoint Blockade: Maintaining a Balance in CD8+ T Cell Responses to Chronic Viral Infections and Cancer
2017 StandoutNobel
Pulmonary Langerhans Cell Histiocytosis-Associated Pulmonary Hypertension
2012
High Frequency of Pulmonary Lymphangioleiomyomatosis in Women With Tuberous Sclerosis Complex
2000
Management of toxicities of immune checkpoint inhibitors
2016
Guidelines for the management of hospital-acquired pneumonia in the UK: Report of the Working Party on Hospital-Acquired Pneumonia of the British Society for Antimicrobial Chemotherapy
2008
Classification and Natural History of the Idiopathic Interstitial Pneumonias
2006
Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial
2010 Standout
Hospital-Acquired Infections Due to Gram-Negative Bacteria
2010 Standout
Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis
2010 Standout
The PI3K Pathway in Human Disease
2017 Standout
Plasmapheresis therapy for diffuse alveolar hemorrhage in patients with small-vessel vasculitis
2003
Primary ciliary dyskinesia: improving the diagnostic approach
2009
Tuberous sclerosis: a GAP at the crossroads of multiple signaling pathways
2005
Chylothorax: Aetiology, diagnosis and therapeutic options
2009 Standout
Comparison of 8 vs 15 Days of Antibiotic Therapy for Ventilator-Associated Pneumonia in Adults
2003 Standout
Intravenous Fluids and Acute Kidney Injury
2017 Standout
Is nitric oxide overproduction the target of choice for the management of septic shock?
2001
A case of Wegener?s granulomatosis with pulmonary bleeding successfully treated with double filtration plasmapheresis (DFPP)
2004
Pulmonary Artery Pressure in Lymphangioleiomyomatosis
2007
Immune related adverse events associated with anti-CTLA-4 antibodies: systematic review and meta-analysis
2015
Carbon Monoxide: Endogenous Production, Physiological Functions, and Pharmacological Applications
2005
A guide to cancer immunotherapy: from T cell basic science to clinical practice
2020 Standout
Molecular mechanisms of mTOR-mediated translational control
2009 Standout
An Official American Thoracic Society Clinical Practice Guideline: The Clinical Utility of Bronchoalveolar Lavage Cellular Analysis in Interstitial Lung Disease
2012 Standout
Ventilator-associated Pneumonia
2002 Standout
The NHLBI Lymphangioleiomyomatosis Registry
2005
Mutational and Radiographic Analysis of Pulmonary Disease Consistent with Lymphangioleiomyomatosis and Micronodular Pneumocyte Hyperplasia in Women with Tuberous Sclerosis
2001
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Physiological Implications of Hydrogen Sulfide: A Whiff Exploration That Blossomed
2012 Standout
Autophagy, mitochondria and oxidative stress: cross-talk and redox signalling
2011 Standout
Clinical iron deficiency disturbs normal human responses to hypoxia
2016 StandoutNobel
Managing Immune Checkpoint-Blocking Antibody Side Effects
2015
Mitochondrial formation of reactive oxygen species
2003 Standout
Hypoxic Pulmonary Vasoconstriction
2012
Mitochondrial Reactive Oxygen Species (ROS) and ROS-Induced ROS Release
2014 Standout
Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
2018 Standout
Systematic Reviews: Synthesis of Best Evidence for Clinical Decisions
1997 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice—Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Sixth Special Issue
2013
Radiographic Profiling of Immune-Related Adverse Events in Advanced Melanoma Patients Treated with Ipilimumab
2015
Mutations in the tuberous sclerosis complex geneTSC2are a cause of sporadic pulmonary lymphangioleiomyomatosis
2000
Toxicities of Immunotherapy for the Practitioner
2015
Control of foreign Ag‐specific Ab responses by Treg and Tfr
2020 StandoutNobel
Comparison of Inflammation, Organ Damage, and Oxidant Stress Induced by Salmonella enterica Serovar Muenchen Flagellin and Serovar Enteritidis Lipopolysaccharide
2002
Treatment of the Immune-Related Adverse Effects of Immune Checkpoint Inhibitors
2016
Guidelines for Preventing Health-Care-Associated Pneumonia, 2003: Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee
2004 Standout
Lymphangioleiomyomatosis
2006
Immune-mediated respiratory adverse events of checkpoint inhibitors
2016
Incidence of and Risk Factors for Ventilator-Associated Pneumonia in Critically Ill Patients
1998 Standout
A Multidimensional Index and Staging System for Idiopathic Pulmonary Fibrosis
2012 Standout
Anti-glomerular basement membrane disease: an update on subgroups, pathogenesis and therapies
2018
Works of Romain Lazor being referenced
Use of variability in national and regional data to estimate the prevalence of lymphangioleiomyomatosis
2011
Safety of Combined Heat and Moisture Exchanger Filters in Long-term Mechanical Ventilation
1997
Microscopic Polyangiitis with Alveolar Hemorrhage A Study of 29 Cases and Review of the Literature
2000
European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis
2009
Pulmonary hypertension in lymphangioleiomyomatosis: characteristics in 20 patients
2012
Endothelin-1 Does Not Mediate the Endothelium-Dependent Hypoxic Contractions of Small Pulmonary Arteries in Rats
1996
<i>DNAI1</i> Mutations Explain Only 2% of Primary Ciliary Dykinesia
2008
TISSUE OXYGENATION AND HEMODYNAMIC RESPONSE TO NO SYNTHASE INHIBITION IN SEPTIC SHOCK
2000
Pulmonary Lymphangioleiomyomatosis: A Study of 69 Patients
1999
Alveolar Hemorrhage in Anti-Basement Membrane Antibody Disease
2007
Low initial KCO predicts rapid FEV1 decline in pulmonary lymphangioleiomyomatosis
2004
Combined pulmonary fibrosis and emphysema syndrome in connective tissue disease
2010
Hypoxic contraction of small pulmonary arteries from normal and endotoxemic rats: fundamental role of NO
1999
Cryptogenic Organizing Pneumonia
2005
L-canavanine, an inhibitor of inducible nitric oxide synthase, improves venous return in endotoxemic rats
1997
Pulmonary Sarcoid-Like Granulomatosis Induced by Ipilimumab
2012
Lymphangioleiomyomatosis
2017
Pulmonary Sarcoid–like Granulomatosis after Multiple Vaccinations of a Long-term Surviving Patient with Metastatic Melanoma
2014